首页> 外文会议>International Conference on Communication Systems and Networks >Technical assessment of a low cost multi-powered continuous positive airway pressure (CPAP) device
【24h】

Technical assessment of a low cost multi-powered continuous positive airway pressure (CPAP) device

机译:低成本多动力持续气道正压(CPAP)装置的技术评估

获取原文

摘要

Worldwide, more than one in 10 babies are born premature [1]. Eleven countries, have preterm birth rates of more than 15%. Prematurity (born before 37 weeks of gestation) is closely linked to acute respiratory infections, which is, a leading cause of death in children under 5 years [2]. Because their lungs are underdeveloped, preemies are especially susceptible to respiratory problems. One such leading cause of global child mortality is Respiratory Distress Syndrome (RDS). Current technology (recommended by WHO) is CPAP (Continuous Positive Airway Pressure), which helps in keeping the alveoli open by providing continuous supply of regulated air/oxygen. This ensures that the babies always have residual air in the lungs, thus, they do not struggle to breathe and are saved of further complications such as hypoxia and even death. A stand-alone CPAP device cost upwards of INR 150,000 ($2300) which is too expensive for most developing world hospitals. In most the hospitals in the resource constrained settings, nasal oxygen therapy is often the solution available, for the babies who are suffering from the respiratory distress. Coeo Labs have developed, Saans is a multi-powered, low-cost, and easy to use CPAP device, which is used to maintain constant residual air pressure in the lungs of neonates and infants (to prevent collapse of the alveoli) while they are being transferred to a higher center for advanced care or in any other clinical setting. The advantage that Saans has over other CPAP devices, is that it can operate on various modes of power, including manual mode (in cases where electricity or compressed oxygen is not available) and is available at 1/3rd to 1/5th the cost of CPAP devices available currently. In this paper, the technical evaluation of Saans, as compared to other standard of care CPAP devices is described. Parameters for comparison have been output pressure and flow rates. These parameters have been obtained from a bench top study of product Saans. For other CPAP devices, the parameters are taken from product datasheets/specifications available in the public domain.
机译:在世界范围内,十分之一的婴儿早产[1]。有11个国家的早产率超过15%。早产(在妊娠37周之前出生)与急性呼吸道感染密切相关,这是5岁以下儿童死亡的主要原因[2]。由于它们的肺不发达,因此早产儿特别容易出现呼吸系统疾病。导致全球儿童死亡的此类主要原因之一是呼吸窘迫综合征(RDS)。当前技术(世卫组织推荐)是CPAP(持续气道正压通气),它通过提供持续供应的空气/氧气来帮助保持肺泡开放。这确保了婴儿始终在肺中残留空气,因此,他们不会呼吸困难,并且避免了其他并发症,例如缺氧甚至死亡。一个独立的CPAP设备的成本高达150,000印度卢比(2,300美元),对于大多数发展中国家的医院来说太贵了。在资源匮乏的大多数医院中,鼻吸氧疗法通常是可解决的方法,适用于患有呼吸窘迫的婴儿。 Coeo Labs已开发出,Saans是一种多功能,低成本且易于使用的CPAP设备,可用于在新生儿和婴儿肺部维持稳定的残余气压(以防止肺泡塌陷)被转移到更高级别的中心接受高级护理或在其他任何临床环境中使用。 Saans与其他CPAP设备相比的优势在于,它可以在各种电源模式下运行,包括手动模式(在无法使用电或压缩氧气的情况下),并且可在1/3 rd 到目前可用的CPAP设备成本的1/5 th 。本文介绍了Saans与其他护理CPAP设备标准相比的技术评估。用于比较的参数是输出压力和流量。这些参数是从产品Saans的台式研究中获得的。对于其他CPAP设备,参数取自公共领域中可用的产品数据表/规格。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号